Abstract
Despite the common approach of bolus drug dosing using a patient’s mass, a more tailored approach would be to use empirically derived pharmacokinetic models. Previously, this could only be possible though the use of computer simulation using programs which are rarely available in clinical practice. Through mathematical manipulations and approximations, a simplified set of equations is demonstrated that can identify a bolus dose required to achieve a specified target effect site concentration. The proposed solution is compared against simulations of a wide variety of pharmacokinetic models. This set of equations provides a near-identical solution to the simulation approach. A boundary condition is established to ensure the derived equations have an acceptable error. This approach may allow for more precise administration of medications with the use of point of care technology and potentially allows for pharmacokinetic dosing in artificial intelligence problems.
Similar content being viewed by others
Notes
At the author’s institution there are over 50 different possible anesthetizing locations.
References
Kim TK, Obara S, Johnson KB (2019) Basic principles of pharmacology. In: Gropper MA, et al. (eds) Miller’s anesthesia, 9th edn. Elsevier, Philadelphia, pp 462–486
Malholtra G, Eckmann DM (2019) Anesthesia for bariatric surgery. In: Gropper MA, et al. (eds) Miller’s anesthesia, 9th edn. Elsevier, Philadelphia, p 1924
Diprivan (Propofol) (2001) Injectable emulsion [package insert], Wilmington, DE: AstraZeneca LP
Ingrande J, Lemmens HJM (2010) Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth 105(Suppl 1):i16–23
Subramani Y, Riad W, Chung F, Wong J (2017) Optimal propofol induction dose in morbidly obese patients: a randomized controlled trial comparing the bispectral index and lean body weight scalar. Can J Anaesth 64(5):471–479
Coetzee JF (2012) Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions. Clin Pharmacokinet 51(3):137–145
Eleveld DJ, Colin P, Absalom AR, Struys MMRF (2018) Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Br J Anaesth 120(5):942–959
Lee B, Lee JR, Na S (2009) Targeting smooth emergence: the effect site concentration of remifentanil for preventing cough during emergence during propofol-remifentanil anaesthesia for thyroid surgery. Br J Anaesth 102(6):775–778
Nho JS, Lee SY, Kang JM et al (2009) Effects of maintaining a remifentanil infusion on the recovery profiles during emergence from anaesthesia and tracheal extubation. Br J Anaesth 103(6):817–821
Shafer SL, Egan T (2016) Target-controlled infusions: surfing USA Redux. Anesth Analg 122(1):1–3
Sarraf E, Mathews DM (2017) Building a Simplified Remifentanil Target Controlled Infusion System. Oral session presented at ANESTHESIOLOGY, Boston, MA
Sarraf E, Mathews DM (2017) Simplified estimation of the volume of distribution at peak effect for remifentanil. Poster session presented at ANESTHESIOLOGY, Boston, MA
Shafer SL, Gregg KM (1992) Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharm 20(2):147–169
Henthorn TK, Krejcie TC, Shanks CA, Avram MJ (1992) Time-dependent distribution volume and kinetics of the pharmacodynamic effector site. J Pharm Sci 81(11):1136–1138
Niazi S (1976) Volume of distribution as a function of time. J Pharm Sci 65(3):452–454
Levitt DG, Schnider TW (2005) Human physiologically based pharmacokinetic model for propofol. BMC Anesthesiol 5(1):4
Cortínez LI (2014) What is the ke0 and what does it tell me about propofol? Anaesthesia 69(5):399–402
Minto CF, Schnider TW, Gregg KM, Henthorn TK, Shafer SL (2003) Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology 99(2):324–333
Wada DR, Drover DR, Lemmens HJ (1998) Determination of the distribution volume that can be used to calculate the intravenous loading dose. Clin Pharmacokinet 35(1):1–7
Lagarias JC, Reeds JA, Wright MH, Wright PE (1998) Convergence properties of the Nelder-mead simplex method in low dimensions. SIAM J Optim 9(1):112–147
Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E (2001) A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 95(2):286–298
Shafer SL. STANPUMP. Open TCI. https://opentci.org/code/stanpump. Accessed 12 July 2018
Minto CF, Schnider TW, Shafer SL (1997) Pharmacokinetics and pharmacodynamics of remifentanil II. Model application. Anesthesiology 86(1):24–33
Schnider TW, Minto CF, Gambus PL et al (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88(5):1170–1182
Schnider TW, Minto CF, Shafer SL et al (1999) The influence of age on propofol pharmacodynamics. Anesthesiology 90(6):1502–1516
Mandel JE. MATLAB. Open TCI. https://opentci.org/code/matlab. Accessed 12 July 2018
Aranake A, Mashour GA, Avidan MS (2013) Minimum alveolar concentration: ongoing relevance and clinical utility. Anaesthesia 68(5):512–522
Kendale S, Kulkarni P, Rosenberg AD, Wang J (2018) Supervised machine-learning predictive analytics for prediction of postinduction hypotension. Anesthesiology 129(4):675–688
Epstein RH, Dexter F, Schwenk ES (2017) Hypotension during induction of anaesthesia is neither a reliable nor a useful quality measure for comparison of anaesthetists' performance. Br J Anaesth 119(1):106–114
Cheung CC, Martyn A, Campbell N et al (2015) Predictors of intraoperative hypotension and bradycardia. Am J Med 128(5):532–538. https://doi.org/10.1016/j.amjmed.2014.11.030
Berezhkovskiy LM (2016) Exploration of PBPK model-calculation of drug time course in tissue using IV bolus drug plasma concentration-time profile and the physiological parameters of the organ. J Pharm Sci 105(8):2453–2458
Krejcie TC, Avram MJ (2012) Recirculatory pharmacokinetic modeling: what goes around, comes around. Anesth Analg 115(2):223–226
Kazama T, Ikeda K, Morita K, Ikeda T, Kikura M, Sato S (2001) Relation between initial blood distribution volume and propofol induction dose requirement. Anesthesiology 94(2):205–210
Krejcie TC, Avram MJ (1999) What determines anesthetic induction dose? It's the front-end kinetics, doctor! Anesth Analg 89(3):541–544
In the Supplemental Digital Content:
Cortínez LI, Anderson BJ, Penna A et al (2010) Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth 105(4):448–456
Cortínez LI, De la Fuente N, Eleveld DJ et al (2014) Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis. Anesth Analg 119(2):302–310
Flood P, Shafer S (2015) Basic principles of pharmacology. In: Flood P, Rathmell JP, Shafer S (eds) Stoelting’s pharmacology & physiology in anesthetic practice, 5th edn. Wolters Kluwer Health, Philadelphia, PA, pp 11–43
Oppenheim AV. Linear time-invariant systems. In: Oppenheim AV, Willsky AS, Hamid S. Signals and systems (2nd ed). Pearson University Press, Pearson, 1997, pp 75–178
Shafer SL, Siegel LC, Cooke JE, Scott JC (1988) Testing computer-controlled infusion pumps by simulation. Anesthesiology 68(2):261–266
Acknowledgements
The author thanks Donald M Mathews, M.D. for his guidance during the writing of the manuscript and William G Tharp, M.D., Ph.D., and Alexander F. Friend, M.S., for their constructive criticism of the manuscript.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
ES: this author designed the study, analyzed the data, and prepared the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author declare that he has no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
10928_2020_9709_MOESM1_ESM.docx
Supplementary file1 (DOCX 2253 kb). Appendix A—Does bolus dosing by mass alone make sense?: This Appendix demonstrates why a patient’s mass is insufficient to calculate a bolus dose of a medication
10928_2020_9709_MOESM2_ESM.docx
Supplementary file2 (DOCX 32 kb). Appendix B—Deriving the critical equations: This Appendix solves the differential equations governing a compartment model following a bolus dose of a medication. It allows the calculation of the volume of distribution at peak effect, and it demonstrates the relationship between the time to peak effect and ke0
10928_2020_9709_MOESM3_ESM.xlsx
Supplementary file3 (XLSX 20 kb). Appendix C—Schnider bolus worksheet: This is an Excel worksheet to calculate the bolus dose of propofol required to achieve a specified Effect Site concentration goal using the Schnider model
10928_2020_9709_MOESM4_ESM.docx
Supplementary file4 (DOCX 231 kb). Appendix D—TCI solution. This Appendix describes how to construct a “human controlled” TCI algorithm using the equations derived in the manuscript and a standard infusion pump. A sample MATLAB code is also attached
About this article
Cite this article
Sarraf, E. Bolus pharmacokinetics: moving beyond mass-based dosing to guide drug administration. J Pharmacokinet Pharmacodyn 47, 573–581 (2020). https://doi.org/10.1007/s10928-020-09709-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10928-020-09709-w